Otrivine Nasal Spray

Otrivine is a leading nasal decongestant brand known worldwide for its active ingredient, xylometazoline. Originally developed in Switzerland, the product is designed to provide rapid relief from nasal congestion caused by colds, hay fever, and sinusitis by reducing the swelling of blood vessels in the nasal passages.

The brand's history is deeply rooted in Swiss pharmaceutical innovation, having been part of the Ciba-Geigy and later Novartis portfolios for several decades. Through a series of joint ventures and corporate restructurings aimed at focusing on specialized healthcare, the brand transitioned into the consumer health sector.

Today, Otrivine is owned by Haleon, a major independent consumer healthcare company that was formed following the demerger of the consumer healthcare business from GSK. While manufacturing remains concentrated in specialized facilities in Europe, notably Switzerland, the brand's distribution and local marketing are handled by various Haleon subsidiaries across the globe, ensuring it remains a staple in pharmacies worldwide.